Skip to main content
PCL. Inc logo

PCL. Inc — Investor Relations & Filings

Ticker · 241820 ISIN · KR7241820000 KO Manufacturing
Filings indexed 684 across all filing types
Latest filing 2020-10-29 Regulatory Filings
Country KR South Korea
Listing KO 241820

About PCL. Inc

http://www.pclchip.com/

PCL, Inc. is a company that develops and manufactures in-vitro diagnostic (IVD) medical devices, specializing in multiplex immunodiagnosis. The company's core offering is based on its proprietary SG Cap™ Technology, a platform for creating advanced diagnostic solutions. Its product portfolio includes automated multi-immune diagnostic systems, blood testing kits, cancer screening tests, and rapid antigen kits. PCL also provides platform services, reagents, and related equipment such as desktop arrayers to the medical and diagnostic fields.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure from a Korean company (PCL) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract amount, counterparty, duration, and terms. In the context of financial filings, this type of material contract disclosure is a standard regulatory announcement that does not fit into specific categories like earnings releases or annual reports, thus it falls under the general regulatory filing category.
2020-10-29 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing from a Korean company (PCL) announcing a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). This type of disclosure is a standard regulatory requirement for material contracts in the Korean market. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2020-10-29 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal disclosure of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by the company PCL. It details the contract amount, counterparty relationship, contract period, and terms. In the context of Korean regulatory filings (DART), this is a standard disclosure of a material contract, which does not fit into specific categories like M&A, dividends, or financial reports. Therefore, it is classified as a general Regulatory Filing (RNS).
2020-10-29 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds issued by the company PCL. It details the number of shares to be issued, the conversion price, and the remaining balance of convertible bonds. This type of filing relates to changes in capital structure and share issuance resulting from debt conversion, which falls under the 'Share Issue/Capital Change' category.
2020-10-26 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by the company PCL. It details the contract amount, counterparty relationship, and contract duration. Since this is a specific regulatory announcement of a business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2020-10-26 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by PCL. It details the contract amount, counterparty nature, and terms. Since this is a specific regulatory disclosure of a material business event (contract signing) that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2020-10-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.